Microsporidiosis epidemiology and demographics: Difference between revisions
Ochuko Ajari (talk | contribs) |
Ahmed Younes (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Microsporidiosis}} | {{Microsporidiosis}} | ||
{{CMG}}; {{Ochuko}} | {{CMG}}; {{Ochuko}};{{AE}}{{AY}} | ||
==Overview== | ==Overview== | ||
Revision as of 13:04, 28 June 2017
|
Microsporidiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Microsporidiosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Microsporidiosis epidemiology and demographics |
|
Risk calculators and risk factors for Microsporidiosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ogheneochuko Ajari, MB.BS, MS [2];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [3]
Overview
Microsporidia are being increasingly recognized as opportunistic infectious agents worldwide.
Epidemiology and Demographics
Microsporidiosis occur in humans worldwide, with a prevalence ranging from 0 and 50%, depending on the geographic location and demographic characteristics of the population involved. Prevalence rates tend to be highest among HIV-infected individuals with diarrhea and with a CD4+ T cells less than 100 cells/mm3 blood.[1] Cases of microsporidiosis have been reported in developed and developing countries and among immunosuppressed and immunocompetent individuals. Microsporidiosis has been reported in South America, Asia, and Africa where antiretroviral therapies are not readily accessible in HIV-infected patients with AIDS and it has also been seen in non-HIV infected persons such as travelers, children, the elderly and organ transplant recipients.[1]
References
- ↑ 1.0 1.1 Didier ES, Weiss LM (2006). "Microsporidiosis: current status". Curr Opin Infect Dis. 19 (5): 485–92. doi:10.1097/01.qco.0000244055.46382.23. PMC 3109650. PMID 16940873.